METHYLPHENIDATE ER 36 MG TAB

Methylphenidate Hydrochloride
$0.6985per EA
DEA Schedule CII

Strength

36 mg/1

Manufacturer

SpecGx LLC

NDC

00406013601

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA202608

On Market Since

12/28/2012

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price History

1W

0.0%

1M

-1.9%

3M

-3.3%

6M

-6.9%

1Y

-17.5%

3Y

-36.5%

5Y

-43.0%

All

-85.2%